Remdesivir Market Size, Share & Growth Report 2032

Remdesivir Market: Industry Perspective

The global remdesivir market size was worth around USD 6.01 billion in 2023 and is predicted to grow to around USD 11.12 billion by 2032 with a compound annual growth rate (CAGR) of roughly 7.20% between 2024 and 2032.

Request Free Sample

The report covers forecasts and analyses for the remdesivir market on a global and regional level. The study provides historical data from 2019 to 2022 and a forecast from 2024 to 2032 based on revenue (USD Billion). The study includes drivers and restraints for the remdesivir market and their impact on the demand over the forecast period. Additionally, the report consists of the study of opportunities available in the remdesivir market on a global as well as regional level.

To give the users of this report a comprehensive view of the remdesivir market we have included a competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein dosage, patient, application, end-user, and regional segments are benchmarked based on their market size, growth rate, and general attractiveness.

Request Free Sample 

Remdesivir Market: Segment Analysis

The global remdesivir market is segmentated into dosage, patient, application, end user, and region.

Based on Dosage, the global remdesivir market is divided into 2.5mg, 5mg, 100mg, and 200mg.

By Patient, the global remdesivir market is categorized into Adult, Pediatric, and Geriatric.

In terms of Application, the global remdesivir market is segmented into Ebola, SARS-COV, MERS-COV, and COVID-19. The End user segment of the Remdesivir Market is categorized into Hospitals, Clinics, Pharmacy & Drug Stores, and Online Pharmacies.

Remdesivir Market: Report Scope

Remdesivir Market: Regional Analysis

The Remdesivir market is expected to be dominated by North America due to high COVID-19 cases, disease prevalence, easy access to the drug, and major market players. Europe follows closely due to growing awareness and the pandemic's impact. Asia Pacific is projected for rapid growth due to frequent viral outbreaks and manufacturing approvals. Latin America and the Middle East and Africa are also expected to see a rise in the Remdesivir market.

Remdesivir Market: Competitive Analysis

The report provides company market share analysis to give a broader overview of the key players in the remdesivir market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the remdesivir market on a global and regional basis. 

The global remdesivir market is dominated by players like:

• Gilead Sciences
• Bright Gene
• Hainan Haiyao
• Kelun Pharma
• Hunan Warrant Pharmaceutical
• Hetero
• Cipla
• Jubilant Lifesciences

The report segments the global Remdesivir market as follows:

Global Remdesivir Market: By Dosage

• 2.5mg
• 5mg
• 100mg
• 200mg

Global Remdesivir Market: By Patient

• Adult
• Pediatric
• Geriatric

Global Remdesivir Market: By Application

• Ebola
• SARS-COV
• MERS-COV
• COVID-19
  • Invasive mechanical ventilation
  • Non-Invasive mechanical ventilation

Global Remdesivir Market: By End-user

• Hospitals
• Clinics
• Pharmacy & Drug Stores
• Online Pharmacies

Global Remdesivir Market: By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa